NEW: Introducing RushData ๐Ÿš€

Jun 19, 2026

๐—•๐—ถ๐—ผ๐—ถ๐—ป๐˜๐—ฟ๐—ผ๐—ปโ€™๐˜€ ๐—ถ๐—ป๐˜๐—ฒ๐—ด๐—ฟ๐—ฎ๐˜๐—ฒ๐—ฑ ๐—ฑ๐—ฎ๐˜๐—ฎ-๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฝ๐—น๐—ฎ๐˜๐—ณ๐—ผ๐—ฟ๐—บ ๐—ณ๐—ผ๐—ฟ ๐—”๐—œ-๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐—ฎ๐—ป๐˜๐—ถ๐—ฏ๐—ผ๐—ฑ๐˜† ๐—ฑ๐—ฒ๐˜€๐—ถ๐—ด๐—ป.

Posted by Biointron Biological

RushData combines high-throughput CHO expression, binding analytics, and early developability profiling to generate structured, actionable datasets for antibody discovery and optimization in days, not weeks!

• 1-day CHO expression for rapid, standardized data generation
• Parallel processing of 3,000+ molecules per batch
• Custom workflows for different targets and antibody modalities
• Early developability assessments to identify potential liabilities sooner

Choose the service level that fits your program:
๐—•๐—ฎ๐˜€๐—ถ๐—ฐ – ๐—ฅ๐—ฎ๐—ฝ๐—ถ๐—ฑ ๐—ฆ๐—ฐ๐—ฟ๐—ฒ๐—ฒ๐—ป๐—ถ๐—ป๐—ด
Expression, titer, and affinity

๐—ฆ๐˜๐—ฎ๐—ป๐—ฑ๐—ฎ๐—ฟ๐—ฑ – ๐—•๐—ถ๐—ป๐—ฑ๐—ถ๐—ป๐—ด ๐—–๐—ต๐—ฎ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ฒ๐—ฟ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป
Expression, concentration, cGE, and affinity

๐—ฃ๐—ฟ๐—ฒ๐—บ๐—ถ๐˜‚๐—บ – ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐˜† ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ถ๐—น๐—ถ๐—ป๐—ด
Binding characterization plus early developability assessments

Learn more ๐Ÿ‘‰https://www.biointron.com/rushdata

Download Attachment

See all Member News